Dominic Smethurst
Chief Tech/Sci/R&D Officer presso CORBUS PHARMACEUTICALS HOLDINGS, INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Dominic Smethurst is a Member at The Royal College of Physicians and a Member at the Faculty of Pharmaceutical Medicine.
He is also the Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. since 2024.
Previously, he held positions such as Vice President-Oncology & Global Therapeutic Area at ICON plc, Chief Medical Officer at Bicycle Therapeutics Plc from 2020 to 2023, Chief Medical Officer at BerGenBio ASA, Chief Medical Officer at Nordic Nanovector ASA in 2020, and Chief Medical Officer at Tusk Therapeutics Ltd.
from 2016 to 2018.
Dr. Smethurst completed his undergraduate degree at the University of Cambridge and his graduate degree at Christ's College (United Kingdom).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 27/02/2024 | 50 000 ( 0.48% ) | 2 M $ | 31/03/2024 | |
| 03/01/2023 | 23 574 ( 0.08% ) | 586 993 $ | 31/03/2024 |
Posizioni attive di Dominic Smethurst
| Società | Posizione | Inizio |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2024 |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Precedenti posizioni note di Dominic Smethurst
| Società | Posizione | Fine |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 31/03/2023 |
| THOR MEDICAL | Chief Tech/Sci/R&D Officer | 10/08/2020 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | - |
| ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Formazione di Dominic Smethurst
| University of Cambridge | Undergraduate Degree |
| Christ's College (United Kingdom) | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| BERGENBIO ASA | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
| Faculty of Pharmaceutical Medicine | |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Health Technology |
- Borsa valori
- Insiders
- Dominic Smethurst
